Nucor Q3 Earnings Down, Misses View

Nucor Corp. (NUE) Thursday reported a sharp decline in third-quarter earnings compared to the prior year. Sales were slightly up, and the company attributed lower earnings of the steel mills segment to the reduction in earnings for the quarter.

Looking ahead to the fourth quarter, the company expects a reduction in earnings, compared to the third quarter due to lower average selling prices and lower volumes. The company projects the largest decline in profitability at its sheet mills.

The company reported third-quarter earnings of 1.799 billion, down from $2.223 billion a year ago. On a per-share basis, earnings were $6.50 compared to $7.28 per share last year.

On average, 8 analysts polled by Thomson Reuters expected the company to earn $6.73 per share. Analysts estimates usually exclude special items.

Net sales were $10.50 billion, down 11 percent from $10.313 billion last year. Wall Street estimate was $9.9 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route. Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie. Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
Follow RTT